Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-Up of the Phase 3 Illuminate-C Trial.

{"title":"Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-Up of the Phase 3 Illuminate-C Trial.","authors":"Anne-Laure Sellier-Leclerc, Daniella Magen, Hadas Shasha-Lavsky, Eva Simkova, Arnaud Devresse, Fitsum Guebre-Egziabher, Mini Michael, John C Lieske, Yaacov Frishberg, Sevcan A Bakkaloglu, Chebl Mourani, Rola Saqan, Richard Singer, Isabella Guzzo, Nune Makarova, Richard Willey, Cristin Kaspar, John M Gansner, Jaap W Groothoff","doi":"10.1053/j.ajkd.2025.01.016","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":" ","pages":""},"PeriodicalIF":9.4000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1053/j.ajkd.2025.01.016","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}